Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Vaccine

• Publication date

  2018-01-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2017.12.018PMID 29254840PMCID PMC5767517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.

  2017cited by this paper
• During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.

  2016cited by this paper
• Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection

  2016cited by this paper
• Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection

  2016cited by this paper
• Soluble CD14 is a nonspecific marker of monocyte activation

  2015cited by this paper
• KLRG1 Impairs CD4+ T Cell Responses via p16ink4a and p27kip1 Pathways: Role in Hepatitis B Vaccine Failure in Individuals with Hepatitis C Virus Infection

  2014cited by this paper
• Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.

  2014cited by this paper
• Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.

  2014cited by this paper
• Older Age Is Associated with Peripheral Blood Expansion of Naïve B Cells in HIV-Infected Subjects on Antiretroviral Therapy

  2014cited by this paper
• Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.

  2014cited by this paper
• Circulating CXCR5+PD-1+ Response Predicts Influenza Vaccine Antibody Responses in Young Adults but not Elderly Adults

  2014cited by this paper
• Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.

  2014cited by this paper
• Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C

  2014cited by this paper
• Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Naïve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine

  2013cited by this paper
• Immune Exhaustion and Immune Senescence: Two Distinct Pathways for HBV Vaccine Failure During HCV and/or HIV Infection

  2013cited by this paper
• Understanding immunosenescence to improve responses to vaccines

  2013cited by this paper
• Plasma Proteome Analysis Reveals Overlapping, yet Distinct Mechanisms of Immune Activation in Chronic HCV and HIV Infections

  2013cited by this paper
• Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection

  2012cited by this paper
• Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection.

  2011cited by this paper
• Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.

  2011cited by this paper
• Plasma levels of soluble CD14 independently predict mortality in HIV infection.

  2011cited by this paper
• Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.

  2011cited by this paper
• Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.

  2011cited by this paper
• Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.

  2011cited by this paper
• CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.

  2011cited by this paper
• Follicular helper CD4 T cells (TFH).

  2011cited by this paper
• Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.

  2011cited by this paper
• Immunization for HIV-positive individuals

  2010cited by this paper
• Interleukin‐7 promotes the survival of human CD4+ effector/memory T cells by up‐regulating Bcl‐2 proteins and activating the JAK/STAT signalling pathway

  2010cited by this paper
• Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.

  2010cited by this paper
• Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.

  2010cited by this paper
• Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis.

  2009cited by this paper
• Virologic and Immunologic Correlates With the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on Highly Active Antiretroviral Treatment

  2009cited by this paper
• Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients.

  2009cited by this paper
• Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.

  2009cited by this paper
• Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.

  2009cited by this paper
• Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

  2008cited by this paper
• Hepatitis A and hepatitis B vaccination responses in persons with chronic hepatitis C infections: A review of the evidence and current recommendations.

  2008cited by this paper
• Intrahepatic levels of CXCR3‐associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C

  2008cited by this paper
• The lymph node in HIV pathogenesis.

  2008cited by this paper
• Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.

  2006cited by this paper
• CD14 Is an Acute-Phase Protein1

  2004cited by this paper
• IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1

  2002cited by this paper
• Clinical significance of elevated serum interferon‐ inducible protein‐10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels

  2001cited by this paper
• Hepatocytes Contribute to Soluble CD14 Production, and CD14 Expression Is Differentially Regulated in Hepatocytes and Monocytes*

  2000cited by this paper
• Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C

  2000cited by this paper
• Characterization of human endotoxin lipopolysaccharide receptor CD14 expression in transgenic mice.

  1999cited by this paper
• Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

  1999cited by this paper
• Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

  1998cited by this paper
• Regulated production of the interferon‐γ‐inducible protein−10 (IP‐10) chemokine by human neutrophils

  1997cited by this paper
• Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils.

  1997cited by this paper

• Association between the systemic immune-inflammatory index and the immune response after hepatitis B vaccination: a cross-sectional analysis of NHANES data

  2025cites this paper
• Ageing with HIV-1: immunological challenges for effective vaccination

  2025cites this paper
• Chronic inflammation degrades CD4 T cell immunity to prior vaccines in treated HIV infection

  2024cites this paper
• Endotoxemia Associated with Liver Disease Correlates with Systemic Inflammation and T Cell Exhaustion in Hepatitis C Virus Infection

  2023cites this paper
• Immune Responses to SARS-CoV-2 Vaccination in People With HIV: A Tale of Two Pandemics

  2022cites this paper
• Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: Randomized control trial.

  2022cites this paper
• Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19

  2022cites this paper
• COVID-19 vaccines for low- and middle-income countries

  2021cites this paper
• The frequency of interleukin‐1β‐producing monocytes is significantly associated with varicella‐zoster responses of nursing home residents

  2021cites this paper
• Naïve CD4+ T Cell Lymphopenia and Apoptosis in Chronic Hepatitis C Virus Infection Is Driven by the CD31+ Subset and Is Partially Normalized in Direct-Acting Antiviral Treated Persons

  2021cites this paper
• Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways

  2021cites this paper
• Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection

  2021influential citation
• Effectiveness of hepatitis A vaccination among people living with HIV in Taiwan: Is one dose enough?

  2020cites this paper
• The Survivor: A Clinical Case of Tetanus in a Non-Immunized, Parenteral Drug User, Former Female Convict with HIV and HCV

  2020influential citation
• Chronic viral infection promotes early germinal center exit of B cells and impaired antibody development

  2019cites this paper
• Elevated Autotaxin and LPA Levels during Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation

  2019cites this paper
• Immune response to hepatitis A vaccine in patients with HIV.

  2019cites this paper
• Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review

  2019cites this paper
• Vaccine-induced ICOS+CD38+ cTfh are sensitive biosensors of age-related changes in inflammatory pathways

  2019cites this paper
• Improved CD4 T-cell profile and inflammatory levels in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination

  2018cites this paper
• Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination

  2018cites this paper